# Sceletium tortuosum

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sceletium-tortuosum
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 6 / 10
**Category:** African
**Also Known As:** Sceletium tortuosum, Kanna, Channa, Kougoed, Canna, Mesembryanthemum tortuosum, Hottentot's fig

## Overview

Sceletium tortuosum is a South African succulent containing mesembrine alkaloids that modulate [serotonin reuptake](/ingredients/condition/mood) and PDE4 activity. The plant demonstrates clinically-supported anxiolytic and mood-enhancing effects through dual-action on serotonergic pathways.

## Health Benefits

• Reduces anxiety and stress response - clinical trials (n=20) showed reduced subjective anxiety and heart rate during stress tasks (moderate evidence)
• Enhances mood and [sleep quality](/ingredients/condition/sleep) - 3-month safety trial (n=37) reported improved stress coping and sleep patterns (preliminary evidence)
• Supports [cognitive function](/ingredients/condition/cognitive) - 3-week trial (n=21) demonstrated positive neurocognitive effects via PDE-4-cAMP-CREB pathways (preliminary evidence)
• Modulates amygdala threat response - pharmaco-fMRI study showed attenuated amygdala activity supporting anxiolytic potential (mechanistic evidence)
• May improve [stress resilience](/ingredients/condition/stress) - unsolicited reports from 3-month trial participants noted better stress management (anecdotal evidence)

## Mechanism of Action

Mesembrine, the primary alkaloid, acts as a selective [serotonin reuptake](/ingredients/condition/mood) inhibitor (SSRI) and phosphodiesterase-4 (PDE4) inhibitor. This dual mechanism increases synaptic serotonin availability while reducing [inflammatory](/ingredients/condition/inflammation) cytokine production. The PDE4 inhibition also elevates cAMP levels, contributing to improved [stress resilience](/ingredients/condition/stress) and mood regulation.

## Clinical Summary

A controlled trial with 20 participants demonstrated significant reductions in subjective anxiety scores and heart rate variability during stress tasks after acute dosing. A 3-month safety study involving 37 subjects reported improvements in perceived stress management and [sleep quality](/ingredients/condition/sleep) scores. Current evidence is preliminary but promising, with most studies involving small sample sizes and short durations. Larger, long-term randomized controlled trials are needed to establish therapeutic efficacy.

## Nutritional Profile

Sceletium tortuosum is not consumed as a food for macronutrient value; it is a succulent plant used as a psychoactive botanical preparation. Its relevance is entirely in its bioactive alkaloid profile rather than conventional nutritional content (negligible protein, fat, carbohydrate, and fiber contribution at typical doses of 25–50 mg standardized extract or 50–200 mg raw plant material). **Key bioactive compounds:** • **Mesembrine** (primary alkaloid, ~0.3–1.3% of dry plant weight depending on fermentation/preparation): Selective [serotonin reuptake](/ingredients/condition/mood) inhibitor (SRI) and potent phosphodiesterase-4 (PDE4) inhibitor; considered the principal anxiolytic and mood-enhancing constituent. Bioavailability is enhanced by traditional fermentation ('kougoed' process), which converts less active alkaloids into mesembrine-type compounds. • **Mesembrenone** (~0.1–0.5% dry weight): Dual SRI and PDE4 inhibitor; contributes to serotonergic activity; relative proportion increases in unfermented material. • **Mesembrenol** (trace to ~0.2%): Minor alkaloid with weaker SRI activity. • **Mesembranol** (trace to ~0.2%): Minor alkaloid contributing to overall pharmacological profile. • **Δ7-Mesembrenone** (variable trace amounts): Present in some chemotypes; biological activity less characterized. • **Total mesembrine-type alkaloids** in standardized commercial extracts (e.g., Zembrin®): Typically standardized to ≥0.35–0.40% total alkaloids, with defined ratios of mesembrine, mesembrenone, mesembrenol, and mesembranol. • **Other constituents:** Trace amounts of oxalic acid, flavonoids, and tannins are present in crude plant material but are not considered pharmacologically relevant at typical doses. **Mineral/vitamin content:** Not nutritionally significant at therapeutic doses (25–50 mg extract); no meaningful contribution of vitamins or minerals. **Bioavailability notes:** Oral bioavailability of mesembrine alkaloids appears adequate based on clinical efficacy at low doses (25 mg Zembrin® extract). Traditional fermentation (anaerobic curing for 2–8 days) significantly alters alkaloid ratios, increasing mesembrine relative to mesembrenone, and is believed to improve tolerability and potency. The alkaloids are lipophilic and likely undergo hepatic first-pass [metabolism](/ingredients/condition/weight-management); sublingual or insufflation routes used traditionally may bypass first-pass effects and increase bioavailability, though clinical data is limited to oral dosing.

## Dosage & Preparation

Clinically studied doses use Zembrin® standardized extract (2% total alkaloids, 0.4% mesembrine): 8-25 mg once daily for up to 3 months. Acute anxiety effects studied at 25 mg single dose. No studies on raw powder or traditional fermented forms. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Common side effects include mild headache, nausea, and drowsiness at higher doses. Potential interactions exist with antidepressants, particularly SSRIs and MAOIs, due to mesembrine's serotonergic activity. Contraindicated in individuals with bipolar disorder or those taking psychiatric medications without medical supervision. Safety during pregnancy and breastfeeding has not been established, so use should be avoided.

## Scientific Research

Clinical evidence consists of small randomized controlled trials in healthy volunteers only, with no studies in clinical populations with diagnosed anxiety or depression. Key trials include a 3-month safety study (n=37, PMID: 23441963), acute [stress response](/ingredients/condition/stress) studies (n=20, PMID: 32761980), and a 3-week neuro[cognitive](/ingredients/condition/cognitive) trial (n=21, PMID: 25389443).

## Historical & Cultural Context

Used for centuries by San and Khoikhoi peoples of South Africa for relieving stress, anxiety, depression, and enhancing mood, traditionally consumed as fermented plant material that was chewed or smoked. Modern interest has revived its ethnobotanical applications in standardized extract form.

## Synergistic Combinations

L-Theanine, Rhodiola rosea, Ashwagandha, Magnesium glycinate, Phosphatidylserine

## Frequently Asked Questions

### What is the active compound in Sceletium tortuosum?

Mesembrine is the primary bioactive alkaloid, typically comprising 0.3-2.3% of dried plant material. Other alkaloids include mesembranol and mesembrenone, which contribute to the plant's psychoactive effects through serotonin pathway modulation.

### How long does Sceletium tortuosum take to work?

Acute effects on anxiety can be observed within 1-2 hours of administration in clinical trials. However, optimal mood and stress management benefits typically develop over 4-8 weeks of consistent use, similar to conventional antidepressants.

### What is the recommended dosage for Sceletium tortuosum?

Clinical studies used 8-25mg of standardized extract containing 0.2-0.5% total alkaloids daily. Traditional preparation methods involve 50-200mg of fermented plant material, though potency varies significantly between preparations.

### Can Sceletium tortuosum be combined with other supplements?

It may synergize with adaptogens like rhodiola or ashwagandha for stress management. However, avoid combining with 5-HTP, St. John's wort, or other serotonergic compounds due to potential serotonin syndrome risk.

### Is Sceletium tortuosum legal in the United States?

Yes, Sceletium tortuosum is legal as a dietary supplement in the US and most countries. It is not controlled under the Controlled Substances Act, though regulatory status may vary by jurisdiction for specific preparations or concentrations.

### What does clinical research show about Sceletium tortuosum's effects on anxiety?

Clinical trials have demonstrated that Sceletium tortuosum reduces both subjective anxiety and heart rate response during stress tasks, with a moderate level of evidence from studies involving 20 participants. These findings suggest the herb may help modulate the body's stress response, though larger and longer-term studies are needed to confirm efficacy across diverse populations. The anxiety-reducing effects appear to be mediated through the herb's active alkaloids and their interaction with PDE-4 inhibition pathways.

### Is Sceletium tortuosum safe for long-term use?

A 3-month safety trial with 37 participants reported improved stress coping and sleep patterns without documented adverse effects, suggesting preliminary safety for extended use. However, long-term safety data beyond 3 months remains limited, and additional research is needed to establish safety profiles for populations such as pregnant women, nursing mothers, or those with specific health conditions. Users should consult with a healthcare provider before initiating long-term supplementation.

### Who would benefit most from taking Sceletium tortuosum?

Individuals experiencing stress, anxiety, or sleep disruption may benefit most from Sceletium tortuosum supplementation, particularly those seeking a botanically-derived alternative to conventional options. The herb may also appeal to people interested in cognitive support, as preliminary evidence suggests positive neurocognitive effects through PDE-4 inhibition. Those with stable baseline health and without contraindications to serotonergic compounds are best positioned to explore this supplement's potential benefits.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*